https://www.evaluate.com/thought-leadership/portfolio-tactics-to-scale-the-300bn-patent-cliff/
Nov 19, 2025 - Read Evaluate’s latest report on portfolio tactics to scale the $300bn patent cliff. Essential reading for pharma, biotech, and investment professionals,...
patent cliffportfoliotacticsscalepharma
https://www.evaluate.com/webinar/tactics-to-scale-the-300bn-patent-cliff/
Nov 18, 2025 - Discover how the looming $300bn patent cliff will reshape biopharma. This webinar explores top expiring drugs, industry risks, and pharma’s evolving growth...
patent cliffcliffhangerportfoliotacticsscale